Epigral Board of Directors

Get the latest insights into the leadership at Epigral. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Maulik Patel Chairman & Managing Director
Mr. Kaushal Soparkar Executive Director
Mr. Ankit Patel Non Exe.Non Ind.Director
Mr. Karana Patel Non Exe.Non Ind.Director
Mr. Darshan Patel Non Exe.Non Ind.Director
Mr. Manubhai Patel Independent Director
Mr. Sanjay Asher Independent Director
Mr. Kanubhai Patel Independent Director
Mr. Raju Swamy Independent Director
Ms. Priyanka Chopra Independent Woman Director

Epigral Share price

EPIGRAL

1811.4

7.20 (-0.40%)
NSE
BSE
Last updated on 29 Aug, 2025 | 15:31 IST
BUYSELL
Today's High

1838.90

Today's Low

1785.00

52 Week Low

1502.35

52 Week High

2406.75

The current prices are delayed, login to your account for live prices

Epigral FAQs

The board at Epigral consists of experienced professionals, including Mr. Maulik Patel , Mr. Kaushal Soparkar , and others, overseeing the company’s strategic and corporate governance.

Directors at Epigral are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Maulik Patel is the current chairman at Epigral.

Executive directors at Epigral are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Epigral adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Epigral, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.